Consolidated statement of income

Download (XLSX, 38 KB)
Consolidated statement of income
€ in millions Note 2020 2019
Sales 4 36,277 35,409
Cost of sales   -25,961 -25,061
Gross profit   10,316 10,348
Selling expenses   -1,057 -1,020
General and administrative expenses 8 -4,373 -4,386
Other operating income 9 367 431
Other operating expenses 9 -148 -126
Gain related to divestitures of Care Coordination activities 3 31 29
Research and development expenses 7 -751 -645
Operating income (EBIT)   4,385 4,631
Interest income 10 93 162
Interest expenses 10 -752 -881
Income before income taxes   3,726 3,912
Income taxes 11 -903 -883
Net income   2,823 3,029
Noncontrolling interests 12 1,116 1,146
Net income attributable to shareholders of Fresenius SE & Co. KGaA   1,707 1,883
       
Earnings per share in € 14 3.06 3.38
Fully diluted earnings per share in € 14 3.06 3.38
The following notes are an integral part of the consolidated financial statements.
Contact us

Fresenius SE & Co. KGaA
Else-Kröner-Str. 1
61352 Bad Homburg v.d.H.
Germany
T +49 (0) 6172 608-2294
pr-fre@fresenius.com

Visit us

Fresenius SE & Co. KGaA

GRI Index

Consolidated statement of comprehensive income